A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects

Status:
Not yet recruiting

Trial end date:
2023-10-01

Target enrollment:

Participant gender:

This study is divided into Stage I and Stage II. It is planned to include 156 subjects who need CRRT treatment for more than 48 hours.

Phase 2

Haisco Pharmaceutical Group Co., Ltd.

Calcium heparin
Heparin